fda compounding semaglutide enforcement november 2025 is moving to restrict mass-marketed compounded GLP-1 products that aren't FDA-approved, warning companies they can't market them as equivalent to approved drugs and signaling stronger to protect patients from unverified FDA to Restrict Ingredients Used

Waibel J, Ziegler M, Nguyen TQ, et al

Realistic timeline expectations Based on aggregated user reports, realistic timelines look like: Order to shipment: 2-7 days depending on stock availability and payment processing

Dehydration Risk Increases GLP-1 users often: eat less drink less feel less thirsty Alcohol: increases fluid loss increases electrolyte imbalance This can lead to: headaches fatigue constipation (already common on GLP-1s) dizziness Hydration becomes much more important

Garca-Borreguero, D

To what extent this relationship translates into alterations in HbA 1c , time in range and total daily dose of insulin in patients with ideal body weight and type 1 diabetes is yet to be determined

Non-Food Strategies Fresh air (walk outside when nauseated) Avoid strong smells Acupressure wrist bands (P6 point) Deep breathing exercises Peppermint tea or candies 6